Amylyx Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Amylyx Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2022 to Q4 2023.
  • Amylyx Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending December 31, 2023 was $303K, a 55.4% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $303K -$377K -55.4% Dec 31, 2023 10-K 2024-02-22
Q3 2023 $383K -$413K -51.9% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $473K -$448K -48.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $572K -$478K -45.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $680K Dec 31, 2022 10-K 2023-03-13
Q3 2022 $796K Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $921K Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.05M Mar 31, 2022 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.